Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;174(12):W116-W117.
doi: 10.7326/L21-0607. Epub 2021 Oct 5.

Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem  1 , Jennifer Yost  2 , Itziar Etxeandia-Ikobaltzeta  1 , George M Abraham  3 , Janet A Jokela  4 , Matthew C Miller  5 , Mary Ann Forciea  6 , Linda L Humphrey  7 ; Scientific Medical Policy Committee of the American College of Physicians*
Affiliations

Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem et al. Ann Intern Med. 2021 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: All financial and intellectual disclosures of interest were declared, and potential conflicts were discussed and managed. Dr. Obley participated in discussion of the practice points but was recused from authorship and voting due to a moderate-level conflict of interest (author of supporting systematic review). Drs. Dunn, Kansagara, and Marcucci participated in the discussion but were recused from authorship and voting due to moderate-level conflicts of interest (authors of recent relevant systematic reviews). A record of disclosures of interest and management of conflicts is kept for each Scientific Medical Policy Committee meeting and conference call and can be viewed at www.acponline.org/about-acp/who-we-are/leadership/boards-committees-councils/scientific-medical-policy-committee/disclosure-of-interests-and-conflict-of-interest-management-summary-for-scientific-medical-policy. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L21-0607.

Update of

References

    1. Qaseem A , Yost J , Etxeandia-Ikobaltzeta I , et al; Scientific Medical Policy Committee of the American College of Physicians. Should remdesivir be used for the treatment of patients with COVID-19? Rapid, living practice points from the American College of Physicians (version 2). Ann Intern Med. 2021;174:673-679. [PMID: ] doi: 10.7326/M20-8101 - DOI - PMC - PubMed
    1. Qaseem A , Yost J , Etxeandia-Ikobaltzeta I , et al. Update alert: should remdesivir be used for the treatment of patients with COVID-19? Rapid, living practice points from the American College of Physicians (version 2) [Letter]. Ann Intern Med. 2021;174:W66-W67. [PMID: ] doi: 10.7326/L21-0389 - DOI - PMC - PubMed
    1. Kaka AS , MacDonald R , Linskens EJ , et al. Update alert: remdesivir for adults with COVID-19 [Letter]. Ann Intern Med. 2021;174:W65. [PMID: ] doi: 10.7326/L21-0375 - DOI - PMC - PubMed
    1. Wilt TJ, Kaka AS, MacDonald R, et al. Rapid Response: COVID-19: Remdesivir for Hospitalized Adults. Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs; 2020. VA ESP Project #09-009.
    1. Wilt TJ , Kaka AS , MacDonald R , et al. Remdesivir for adults with COVID-19: a living systematic review for American College of Physicians practice points. Ann Intern Med. 2021;174:209-220. [PMID: ] doi: 10.7326/M20-5752 - DOI - PMC - PubMed

MeSH terms